{"url_path":"/sec/dftx/8-k/2026-06-24/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 ****Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-24","source_url":"https://www.sec.gov/Archives/edgar/data/1813814/0001104659-26-077354-index.html","accession_number":"0001104659-26-077354","cik":"0001813814","ticker":"DFTX","issuer_name":"Definium Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1813814/0001104659-26-077354-index.html","primary_entity_key":"0001813814","primary_entity_name":"Definium Therapeutics, Inc."},"word_count":46,"has_tables":true,"body_markdown":"** **\n\n**Item 8.01****Other Events.**\n\n** **\n\nThe Company issued press releases announcing the\nlaunch and pricing of the Offering on June 22, 2026 and June 23, 2026, respectively. Copies of these press releases are attached hereto\nas Exhibit 99.1 and Exhibit 99.2, respectively, and are incorporated herein by reference."}